Innovative Pharmaceutical Biotech Limited (0399.HK)
HKD 0.18
(-1.67%)
HKD 0.18
(-1.67%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 14.27 Million HKD | -33.8% |
| 2022 | 21.56 Million HKD | -15.41% |
| 2021 | 25.48 Million HKD | 11.84% |
| 2020 | 22.79 Million HKD | -32.93% |
| 2019 | 33.97 Million HKD | 18.48% |
| 2018 | 28.67 Million HKD | 8.57% |
| 2017 | 26.41 Million HKD | 12.97% |
| 2016 | 23.38 Million HKD | -26.02% |
| 2015 | 31.6 Million HKD | -4.78% |
| 2014 | 33.19 Million HKD | -94.18% |
| 2013 | 570.5 Million HKD | 1014.45% |
| 2012 | 51.19 Million HKD | -10.47% |
| 2011 | 57.17 Million HKD | 130.44% |
| 2010 | 24.81 Million HKD | -9.74% |
| 2009 | 27.48 Million HKD | 104.57% |
| 2008 | -600.9 Million HKD | -3696.7% |
| 2007 | 16.7 Million HKD | 102.17% |
| 2006 | 8.26 Million HKD | 14.4% |
| 2005 | 7.22 Million HKD | -15.92% |
| 2004 | 8.59 Million HKD | -81.98% |
| 2003 | 47.68 Million HKD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 FY | 14.27 Million HKD | -33.8% |
| 2023 Q1 | 161.83 Million HKD | 1084.75% |
| 2023 Q2 | 6.59 Million HKD | -95.93% |
| 2023 Q3 | 3.85 Million HKD | -41.51% |
| 2023 Q4 | 7.74 Million HKD | 100.96% |
| 2022 Q3 | 6.73 Million HKD | -17.12% |
| 2022 Q4 | 13.66 Million HKD | 102.76% |
| 2022 Q1 | 4.04 Million HKD | -59.37% |
| 2022 Q2 | 8.12 Million HKD | 101.06% |
| 2022 FY | 21.56 Million HKD | -15.41% |
| 2021 FY | 25.48 Million HKD | 11.84% |
| 2021 Q1 | 117.59 Million HKD | 1200.01% |
| 2021 Q2 | 15.45 Million HKD | -86.86% |
| 2021 Q3 | 4.93 Million HKD | -68.07% |
| 2021 Q4 | 9.95 Million HKD | 101.6% |
| 2020 Q2 | 7.86 Million HKD | 105.78% |
| 2020 FY | 22.79 Million HKD | -32.93% |
| 2020 Q3 | 7.45 Million HKD | -5.18% |
| 2020 Q1 | 3.82 Million HKD | -60.85% |
| 2020 Q4 | 9.04 Million HKD | 21.31% |
| 2019 FY | 33.97 Million HKD | 18.48% |
| 2019 Q1 | 18.34 Million HKD | 75.13% |
| 2019 Q2 | 12.88 Million HKD | -29.79% |
| 2019 Q3 | 20.18 Million HKD | 56.67% |
| 2019 Q4 | 9.76 Million HKD | -51.64% |
| 2018 Q3 | 10.47 Million HKD | -81.29% |
| 2018 Q4 | 10.47 Million HKD | 0.0% |
| 2018 Q2 | 56 Million HKD | 0.0% |
| 2018 Q1 | 56 Million HKD | 212.07% |
| 2018 FY | 28.67 Million HKD | 8.57% |
| 2017 FY | 26.41 Million HKD | 12.97% |
| 2017 Q3 | 17.94 Million HKD | -62.33% |
| 2017 Q2 | 47.63 Million HKD | 0.0% |
| 2017 Q1 | 47.63 Million HKD | 75.15% |
| 2017 Q4 | 17.94 Million HKD | 0.0% |
| 2016 Q4 | 27.19 Million HKD | 0.0% |
| 2016 Q1 | 14.14 Million HKD | -77.21% |
| 2016 Q2 | 14.14 Million HKD | 0.0% |
| 2016 Q3 | 27.19 Million HKD | 92.25% |
| 2016 FY | 23.38 Million HKD | -26.02% |
| 2015 Q1 | 25.43 Million HKD | -32.14% |
| 2015 Q3 | 62.06 Million HKD | 144.05% |
| 2015 Q2 | 25.43 Million HKD | 0.0% |
| 2015 Q4 | 62.06 Million HKD | 0.0% |
| 2015 FY | 31.6 Million HKD | -4.78% |
| 2014 Q1 | 167 Million HKD | 0.0% |
| 2014 FY | 33.19 Million HKD | -94.18% |
| 2014 Q4 | 37.47 Million HKD | 0.0% |
| 2014 Q3 | 37.47 Million HKD | -77.56% |
| 2014 Q2 | 167 Million HKD | 0.0% |
| 2013 FY | 570.5 Million HKD | 1014.45% |
| 2013 Q2 | 14.01 Million HKD | -22.25% |
| 2013 Q4 | - HKD | 0.0% |
| 2013 Q1 | 18.02 Million HKD | -32.34% |
| 2012 Q2 | 5.77 Million HKD | 0.0% |
| 2012 Q4 | 26.64 Million HKD | 361.72% |
| 2012 Q3 | 5.77 Million HKD | 0.0% |
| 2012 FY | 51.19 Million HKD | -10.47% |
| 2011 FY | 57.17 Million HKD | 130.44% |
| 2010 FY | 24.81 Million HKD | -9.74% |
| 2009 FY | 27.48 Million HKD | 104.57% |
| 2008 FY | -600.9 Million HKD | -3696.7% |
| 2007 FY | 16.7 Million HKD | 102.17% |
| 2006 FY | 8.26 Million HKD | 14.4% |
| 2005 FY | 7.22 Million HKD | -15.92% |
| 2004 FY | 8.59 Million HKD | -81.98% |
| 2003 FY | 47.68 Million HKD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 204.08 Million HKD | 93.006% |
| China Overseas Nuoxin International Holdings Limited | 38.32 Million HKD | 62.757% |
| Prosperous Future Holdings Limited | 118.15 Million HKD | 87.919% |
| Huasheng International Holding Limited | 153.46 Million HKD | 90.699% |
| Fourace Industries Group Holdings Limited | 57.65 Million HKD | 75.243% |
| Evergreen Products Group Limited | 152.17 Million HKD | 90.62% |
| EC Healthcare | 597.44 Million HKD | 97.611% |
| Ming Fai International Holdings Limited | 357.68 Million HKD | 96.009% |
| Blue Moon Group Holdings Limited | 4.4 Billion HKD | 99.676% |
| SuperRobotics Holdings Limited | 15.16 Million HKD | 5.851% |
| Takbo Group Holdings Limited | 65.71 Million HKD | 78.28% |
| Hyfusin Group Holdings Limited | 196.91 Million HKD | 92.751% |